- Home
- ATER vs GDTC Comparison
ATER vs GDTC Comparison
Compare ATER & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- GDTC
- Stock Information
- Founded
- ATER 2014
- GDTC 2018
- Country
- ATER United States
- GDTC Singapore
- Employees
- ATER N/A
- GDTC N/A
- Industry
- ATER Home Furnishings
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- GDTC Health Care
- Exchange
- ATER Nasdaq
- GDTC Nasdaq
- Market Cap
- ATER 10.3M
- GDTC 24.2M
- IPO Year
- ATER N/A
- GDTC 2023
- Fundamental
- Price
- ATER $1.02
- GDTC $2.28
- Analyst Decision
- ATER
- GDTC Buy
- Analyst Count
- ATER 0
- GDTC 1
- Target Price
- ATER N/A
- GDTC $5.00
- AVG Volume (30 Days)
- ATER 126.5K
- GDTC 105.3K
- Earning Date
- ATER 11-10-2025
- GDTC 01-01-0001
- Dividend Yield
- ATER N/A
- GDTC N/A
- EPS Growth
- ATER N/A
- GDTC N/A
- EPS
- ATER N/A
- GDTC N/A
- Revenue
- ATER $85,668,000.00
- GDTC $573,193.00
- Revenue This Year
- ATER N/A
- GDTC $5.37
- Revenue Next Year
- ATER $7.48
- GDTC N/A
- P/E Ratio
- ATER N/A
- GDTC N/A
- Revenue Growth
- ATER N/A
- GDTC 63.03
- 52 Week Low
- ATER $0.90
- GDTC $1.65
- 52 Week High
- ATER $3.50
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- ATER 44.33
- GDTC 61.26
- Support Level
- ATER $1.04
- GDTC $1.95
- Resistance Level
- ATER $1.12
- GDTC $2.43
- Average True Range (ATR)
- ATER 0.08
- GDTC 0.18
- MACD
- ATER -0.01
- GDTC 0.02
- Stochastic Oscillator
- ATER 11.96
- GDTC 71.00
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.